Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ASPENBIO PHARMA INC Financial Overview

  • Income Statement: APPY

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 821,442.00 848,896.00 -27,454.00 -3.34%
    Gross Profit 239,766.00 233,264.00 6,502.00 2.71%
    Net Income Before Extra Items/Preferred Div -9.57 M -6.20 M -3.37 M 35.20%
    Operating Income -10.17 M -6.45 M -3.73 M 36.63%
  • Cash Flow: APPY

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -1.21 M 26.76 M -27.97 M 2,314.25%
    Net Cash Flow - Investing -2.09 M 822,918.00 -2.92 M 139.29%
    Net Cash Flow/Operating Activities -6.44 M -12.09 M 5.65 M -87.71%
  • Balance Sheet: APPY

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 24.19 M 31.66 M -7.48 M -30.91%
    Total Liabilities 6.30 M 5.16 M 1.14 M 18.11%
    Shareholders Equity 17.89 M 26.50 M -8.62 M -48.16%
  • Key Ratios / Statistics: APPY

    • Valuation

      Price/Earnings (TTM) -19.90
      Price/Sales (TTM) 234.16
      Price/Book (MRQ) 6.89
      Price/Cash Flow (TTM) -5.37
    • Profitability

      Gross Margin 29.19
      Operating Margin -1,238.18
      Profit Margin -1,164.82
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 6.38
      Current Ratio (MRQ) 5.13
      Long Term Debt-to-Equity (MRQ) 21.81
    • Management Effectiveness

      Return on Equity (TTM) -43.28
      Return on Assets (TTM) -48.58
      Return on Investments (TTM) -36.83